Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.
about
Insights into the posttranslational structural heterogeneity of thyroglobulin and its role in the development, diagnosis, and management of benign and malignant thyroid diseasesDefinition of the upper reference limit for thyroglobulin antibodies according to the National Academy of Clinical Biochemistry guidelines: comparison of eleven different automated methodsA Study on Serum Antithyroglobulin Antibodies Interference in Thyroglobulin Measurement in Fine-Needle Aspiration for Diagnosing Lymph Node Metastasis in Postoperative PatientsThyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes.High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma.First Steps toward Harmonization of LC-MS/MS Thyroglobulin AssaysDownregulation of LSD1 suppresses the proliferation, tumorigenicity and invasion of papillary thyroid carcinoma K1 cells.Characterization of a new highly sensitive immunometric assay for thyroglobulin with reduced interference from autoantibodiesPerformance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer.Comparison of Thyroglobulin Measurements Using Three Different Immunoassay Kits: A BRAMHS Tg-Plus RIA Kit, a BRAMHS hTg Sensitive Kryptor Kit, and a Beckman Coulter ACCESS Immunoassay Kit.Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody.Circulating thyroid cancer biomarkers: Current limitations and future prospects.Thyroglobulin Antibody Screen Prior to Mass Spectrometry Provides Measurable Cost Savings and Optimal Laboratory Utilization.Clinical impact of thyroglobulin (Tg) and Tg autoantibody (TgAb) measurements in needle washouts of neck lymph node biopsies in the management of patients with papillary thyroid carcinoma.Measurement of thyroglobulin, calcitonin, and PTH in FNA washout fluids.Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital.Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma.Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies.Serum positive thyroglobulin antibodies: an old problem with new questions.Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up.Serum thyroglobulin as a biomarker of iodine deficiency in adult populations.Evaluation of the highly sensitive Roche thyroglobulin II assay and establishment of a reference limit for thyroglobulin-negative patient samples.Routine thyroglobulin, neck ultrasound and physical examination in the routine follow up of patients with differentiated thyroid cancer-Where is the evidence?
P2860
Q28078289-9A17D7C3-D48B-4273-B61A-0512A813D52CQ33812382-DEFA65FB-73BF-4486-8500-4F06363DBEA6Q35677418-D0530D3B-0DC8-4BD8-AD6B-3BC9E9894530Q35916507-135AED19-25A8-4E0D-8636-9CEF032BAA81Q36265557-C78C83EA-9098-44E2-8E9B-124E0FF18B53Q36693015-15AD5DD7-8D50-4975-BF15-67199BECEE79Q36740912-DDEDFA72-8D15-47CF-B6D7-2C21B413B168Q36924078-2A2F21AE-97BD-41F0-B362-224F12CDDEB8Q37084125-26E23CAF-9B78-4A8D-8646-16FB11E5BFA4Q37316042-841A0F78-CA96-4EFC-AA82-20AFC4B28936Q37736235-9552FD8C-70E4-4C09-A81A-7D8B1FA60218Q38685267-42A52F7C-B140-4AB5-AD0B-EADE84086F66Q38844250-6FA99D1D-5834-406A-9480-6CEA07BC8615Q38948040-DB1CA6ED-99B0-429C-8021-1745A0F53C04Q38996019-18185F51-578A-4CB3-860E-CAB555218D58Q47120994-B917B9A8-1CCF-42FB-8EB6-27F67FC2C2B2Q48126648-E2DD56FF-A9B0-44DE-B528-D4C0BB345177Q50056831-D4711798-B6A8-4B57-8AA1-60645D7D7C51Q51010930-31BE04B7-4AA5-44E3-B315-7C58D98A2942Q54939965-27017D52-BAD1-4B26-ADF0-535D920E500DQ55059573-02858EDB-9270-48AC-A0C6-41E28327CFA1Q55069933-255C95A3-1E5C-446F-B768-40077B80FCFEQ58733117-851C2158-51CE-4E03-8E9A-799DAADAE013
P2860
Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Serum thyroglobulin (Tg) monit ...... toantibody misclassifications.
@en
type
label
Serum thyroglobulin (Tg) monit ...... toantibody misclassifications.
@en
prefLabel
Serum thyroglobulin (Tg) monit ...... toantibody misclassifications.
@en
P2093
P2860
P356
P1476
Serum thyroglobulin (Tg) monit ...... toantibody misclassifications.
@en
P2093
Carole Spencer
Ivana Petrovic
Jonathan LoPresti
Shireen Fatemi
P2860
P304
P356
10.1210/JC.2014-1203
P407
P577
2014-12-01T00:00:00Z